212-896-1267 For more information, please contact: Investor Contact: Allison Soss KCSA Strategic Communications Email: [email protected] Phone: 212-896-1267 Media Contact: Nick Opich / Brittany Tibaldi KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 347-487-6794 On behalf of the Board of Directors:
Wesana Health is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury (TBI). Through extensive clinical research and academic partnerships, Wesana Health is developing evidence-based formulations and protocols that empower patients to overcome neurological, ...
Wesana Health is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury (TBI). Through extensive clinical research and academic partnerships, Wesana He
856-986-1313 Phone Number 856-986-1313 WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States. Lists Featuring This Company Midwestern US Health Care Companies (Top 10K)
212-896-1206 For more information, please contact: Media Contact: Nick Opich / Annie Graf KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 786-390-2644. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: (773) 236-7972. Source: Wesana Health Released September 14, 2021
Wesana Health is creating and deploying therapies to improve how we treat the brain. Through our clinical research and academic partnerships, we’re developing new ways to help overcome neurological and psychological challenges. Our focus. TBI. At least 1.4 million cases of TBI occur each year in the US, with symptoms such as memory loss
Wesana Health Announces Closing of PsyTech Acquisition. CHICAGO and TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE: WESA, OTCQB: WSNAF
773-236-7972 For more information, please contact: Investor Contact: Keenan Gentry Email: [email protected] Phone: 773-236-7972. Media Contacts: Nick Opich / Fallon Carter KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: 773-236-7972
773-236-7972 For more information, please contact: Investor Contact: Keenan Gentry Email: [email protected] Phone: 773-236-7972. Media Contacts: Nick Opich / Fallon Carter KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: 773-236-7972
Apple iPhone 13 pro max 256gb Sierra Blue mobile phone with Apple Care Warranty. Highlights: Camera: 12 MP + 12 MP + 12 MP. Display size 6.7 inches (17.01 cm) Performance Apple A15 Bionic. Storage 256GB. Launch Date September 14, ...
Debut Diamonds Announces Reverse Takeover Transaction with Wesana Health and Brokered Financing Led by Stifel GMP. Toronto, Ontario--(Newsfile Corp. - February 2, 2021) - Debut Diamonds Inc. (CSE: DDI) ("Debut Diamonds" or the "Company") announces that it has entered into a binding agreement (the "Agreement") dated February 2, 2021 with WeSana ...
212-896-1267 For more information, please contact: Investor Contact: Allison Soss KCSA Strategic Communications Email: [email protected] Phone: 212-896-1267 Media Contact: Nick Opich / Annie Graf KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 786-390-2644 On behalf of the Board of Directors: Daniel Carcillo, Chief ...
773-236-7972 For more information, please contact: Investor Contact: Keenan Gentry Email: [email protected] Phone: 773-236-7972. Media Contacts: Nick Opich / Fallon Carter KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: 773-236-7972
212-896-1206 Contact Us . Contact Us Email: Wesana@kcsa.com Phone: 212-896-1206. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: 773-236-7972. Recommended Stories.
773-236-7972 For more information, please contact: Investor Contact: Keenan Gentry Email: [email protected] Phone: 773-236-7972. Media Contact: Nick Opich / Annie Graf KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 786-390-2644. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: (773) 236-7972
212-896-1267 Phone: 212-896-1267 Media Contact: Nick Opich / Annie Graf KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 786-390-2644 On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: (773) 236-7972
For more information about the conference, or to schedule a one-on-one meeting with Wesana's management team, please contact KCSA Strategic Communications at Wesana@kcsa.com About Virtual Investor